Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Surface Oncology to Collaborate with Merck on Immuno-Oncology Study Evaluating SRF388, .
Surface Oncology, Inc.March 9, 2021 GMT
CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today it has entered into a clinical trial collaboration with Merck, known as MSD outside the United States and Canada, through a subsidiary, to evaluate the safety and efficacy of combining Surface’s SRF388, an investigational antibody therapy targeting IL-27, with Merck’s KEYTRUDA® (pembrolizumab), the first anti-PD-1 therapy approved in the United States. This combination will be studied as a component of the first-in-human Phase 1 study of SRF388 and will be evaluated in patients with solid tumors, with a focus on patients with liver c
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Safe and Sustainable Vaping: Swissx Launches Tobacco Line and E-Cig Replacement products
SwissxMarch 9, 2021 GMT
Los Angeles, CA | Gstaad, Switzerland, March 09, 2021 (GLOBE NEWSWIRE) Swissx, the owner of the patents that power vape products made by leading e-cig brands such as IQOS, Mark-10, NJOY, Pax Labs and Juul, has entered the tobacco vape sector with all-natural nicotine extracts from tobacco grown on sustainable, cooperative farms in California and high in the Swiss Alps. Founder Alki David also announced that Swissx has begun shipping it’s own pods and replacement parts, manufactured with ceramic and glass, citing the dangers of both personal injury and cancer risk poised by major e-cig brands’ plastic parts. The new products are already arriving in 7-11s and other major convenience store chains, and are also selling at Swissx.com.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Corvus Raises $100M in Series C Financing to Further Advance Its Mission of Transforming Commercial Insurance
March 10, 2021 GMT
Left: Mike Lloyd, Co-Founder, Chief Product Officer. Right: Phil Edmundson, Founder, Chief Executive Officer. (Photo: Business Wire)
Left: Mike Lloyd, Co-Founder, Chief Product Officer. Right: Phil Edmundson, Founder, Chief Executive Officer. (Photo: Business Wire)
BOSTON (BUSINESS WIRE) Mar 10, 2021
Corvus Insurance, the leading provider of smart commercial insurance products powered by AI-driven risk data, today announced it has secured $100 million in Series C funding in a round led by global venture capital and private equity firm Insight Partners, and including all of its previous institutional investors, increasing Corvus’s valuation to $750 million. This latest investment, following last year’s $33 million Series B round, brings Corvus’s total a